Envestnet Asset Management Inc Vascular Biogenics Ltd. Transaction History

Envestnet Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	BUY	$1.22 - $1.95 $150 - $239	123 Added 0.32%	38,097 $61,000
Q1 2022 May 04, 2022	BUY	$1.15 - $1.97 $43,670 - $74,808	37,974 New	37,974 $64,000
Q2 2021 Aug 04, 2021	SELL	$1.69 - $2.67 $24,979 - $39,465	-14,781 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$1.79 - $2.91 $2,518 - $4,094	1,407 Added 10.52%	14,781 $30,000
Q4 2020 Feb 02, 2021	BUY	$1.07 - $2.0 $14,310 - $26,748	13,374 New	13,374 $25,000
Q3 2020 Oct 09, 2020	SELL	$1.11 - $1.4 $51,167 - $64,535	-46,097 Closed	0 $0
Q2 2020 Jul 08, 2020	BUY	$1.12 - $1.63 $11,718 - $17,054	10,463 Added 29.36%	46,097 $59,000
Q1 2020 Apr 23, 2020	BUY	$0.96 - $1.57 $34,208 - $55,945	35,634 New	35,634 $48,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.